Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium bicarbonate plus saline versus saline hydration for prevention of amphotericin B-induced nephrotoxicity
IRCT20161010030246N4Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of sodium bicarbonate and sodium chloride in drug-induced nephropathy (DIN) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Nephrotoxicity of amphotericin B, Blood urea nitrogen and 2 more. Started Oct 2018; status: completed.
02
Drugs
sodium bicarbonatesodium chloride
03
Conditions
drug-induced nephropathy (DIN)
Beyond the preview
Go deeper on IRCT20161010030246N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161010030246N4.